|
|
|
|
|
|
| Abstract Search | Browse Program and Abstracts | Schedule-at-a-Glance | Conference Mission & Sponsors | Program Committee | Contact Us |
| # | Title |
|---|---|
| 188 | Whole-Killed-Particle Vaccines in SIV Model Systems
L. E. Henderson*, E. Chertova, R. C. Sowder II, J. W. Bess, Jr., J. Lifson, and L. O. Arthur AIDS Vaccine Program, SAIC Frederick, MD, USA |
| 189 | Constitutively Dead, Conditionally Live HIV-1 Genomes: Ex Vivo Implications for a Live-Virus Vaccine
M. Khoroshev*1, P. Marx2,3, J. Orenstein4, K.-T. Jeang5, and S. Smith1 1St. Michael’s Med. Ctr. and New Jersey Med. Sch.-UMDNJ, Newark, USA; 2Tulane Region. Primate Res. Ctr., Covington, LA, USA; 3The Rockefeller Univ., New York, NY, USA; 4George Washington Univ. Sch. Med., Washington, DC, USA; and 5NIAID/NIH, Bethesda, MD, USA |
| 190 | Defining Host Cell Surface Proteins Incorporated into Virus-Like Particles Following Transfection with a Multi-Gene HIV-1 DNA Vaccine Construct
B. Li*1, J. Smith2, H. Robinson2, T. Folks1, S. Butera1, and D. Ellenberger1 1CDC, Atlanta, GA, USA and 2Vaccine Res. Ctr. of Emory Univ., Atlanta, GA, USA |
| 191 | Designing Whole-Killed Virus Vaccines
E. Chertova*, J. W. Bess, Jr., J. M. Hilburn, T. M. Schaden, R. C. Sowder II, J. Lifson, L. O. Arthur, and L. E. Henderson AIDS Vaccine Program, SAIC Frederick, MD, US |
| 192 | Development of an Inactivated HIV Vaccine
P. O. Ilyinskii*, L. Lallos, and T. Castor Aphios Corp., Woburn, MA, USA |
| 192a | Enhanced Production of Primary Isolates of HIV-1 in CD4-Enriched Cell Substrate
C. Wu*1,2, C. Evans3, and G. Vyas1 1Univ. of California San Francisco Sch. of Med., USA; 2San Francisco State Univ., CA, USA; and 3ARC Northern California Blood Ctr., Oakland, USA |